Reducing Waste In Combo Product Reviews: FDA Goes Lean
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency disclosed plans to leverage "lean" management techniques, frequently employed in the private sector and by health care organizations, to streamline the process for reviewing new combination products.
You may also be interested in...
Gottlieb Adds A No. 2: Sherman Is US FDA Principal Deputy Commissioner
Rachel Sherman takes over a position that has not been filled permanently since Josh Sharfstein left in 2011.
Finally … Rachel Sherman Takes Califf's Old FDA Job
After months of speculation, FDA veteran Rachel Sherman becomes deputy commissioner for medical products and tobacco.
Combo Product Reforms Are A Priority For Next User Fee Round, FDA Officials Say
Top FDA officials, including CDRH Director Jeffrey Shuren and FDA Deputy Commissioner Robert Califf, are sending strong signals that the designation and review processes for combination products are due for a significant reassessment. That should be a priority topic of upcoming user fee negotiations with industry, they say.